|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
Back to Reuters Health News Archives
Reuters Health News: 01-04-2005
MEULABOH/BANDA ACEH, Indonesia (Reuters) - Hungry and filthy, thousands of Indonesians queued for water on Tuesday as aid deliveries to tsunami-ravaged Aceh province hit new snags and cases of disease and infection among survivors emerged.
NEW YORK (Reuters Health) - Pregnant women who live in areas with high levels of air pollution may give birth to slightly smaller babies, according to U.S. government researchers.
WASHINGTON (Reuters) - More than 70 percent of patients who took painkillers such as ibuprofen for more than three months suffered damage to their small intestines, U.S. researchers reported on Monday.
WASHINGTON (Reuters) - No one really knows which diets work and which are a waste of time, with the possible exception of Weight Watchers, U.S. researchers reported on Monday.
BERLIN (Reuters) - German scientists have found a new way to prevent the HIV virus from replicating, offering hope in the face of the virus's increasing resistance to existing drugs.
WASHINGTON (Reuters) - Pricey pacemakers that regulate the heart's upper and lower chambers separately are worth the extra cost because they help keep patients out of the hospital, U.S. researchers reported on Monday.
CHICAGO (Reuters) - Shares of StemCells Inc. rose 11 percent on Tuesday as the company announced plans to start an early-stage clinical trial involving the use of brain stem cells to treat Batten disease, a rare but fatal genetic disease that attacks the central nervous systems of children.
WASHINGTON (Reuters) - Stem cells taken from tiny monkey embryos and implanted in the brain reversed some of the Parkinson's symptoms in monkeys used to study the disease, Japanese researchers reported on Monday.
CHICAGO (Reuters) - Shy children tend to have muted reactions to joy or anger in the facial expressions of others, inhibitions that may lead to the anxieties many experience later in life, Italian researchers said on Monday.
WASHINGTON (Reuters) - The U.S. drug safety officer who warned months ago about risks from Merck & Co. Inc.'s painkiller Vioxx won clearance to publish a study arguing the now-recalled drug may have caused up to 139,000 heart attacks and strokes, his attorney said on Monday.
|
|